Latest Industry Insights

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.

In this interview, we explore how Cerno’s vendor-neutral software solutions enhance mass spectrometry data analysis.

Seer joined Technology Networks for a conversation about its new Proteograph® Product Suite at ASMS 2025.

Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.

David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.

In this interview, Susan Bird, senior manager at Thermo Fisher Scientific, discusses the analytical challenges of identifying low-level exposures and how cutting-edge mass spectrometry platforms are advancing exposomics research.

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.